Metraipolis › archive › dc_f364c8403f6f

Use of microbiome analysis as a complementary endpoint in clinical trials — Europe PMC PMID:41280693

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41280693
DOI
10.1016/j.isci.2025.113754
License (as archived)
solo-consultazione
Archived
2026-11-09T08:27:50.319Z
SHA-256 of the archived text
8c3577652861ec1bb5cd2ca6abe3a4ee5ba7d022ad30eaee9fe028260af1f645
Stable URL of this page
https://metraipolis.com/documento/dc_f364c8403f6f

How to cite

Use of microbiome analysis as a complementary endpoint in clinical trials — Europe PMC PMID:41280693 — Europe PMC (en), https://europepmc.org/article/MED/41280693 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f364c8403f6f (Metraipolis archive dc_f364c8403f6f, sha256 8c3577652861ec1bb5cd2ca6abe3a4ee5ba7d022ad30eaee9fe028260af1f645)
BibTeX
@misc{dcf364c8403f6f,
  title = {Use of microbiome analysis as a complementary endpoint in clinical trials — Europe PMC PMID:41280693},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41280693},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f364c8403f6f; sha256 8c3577652861ec1bb5cd2ca6abe3a4ee5ba7d022ad30eaee9fe028260af1f645},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280693. Agents can read the archived copy with the MCP tool read_document.